IL33 and neoplasm: IL-33, which binds to the IL-1R1 receptor, causes the accumulation of immunosuppressive cells, decreases natural anti-tumor immunity, increases cell proliferation, and stimulates angiogenesis, all of which contribute to tumor progression [101].